Eribulin is now available under national reimbursement in Italy for women with locally advanced or metastatic breast cancer

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 646, 2012-02-04 , pp. 11-11(1)

Publisher: Adis International

Keywords: Advanced-breast-cancer, treatment; Eribulin, therapeutic use; Reimbursement

Document Type: Short communication

Publication date: 2012-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers